Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside

Gordon McLennan, Stacy L. Bennett, Shenghong Ju, Andriy Babsky, Navin Bansal, Michelle L. Shorten, Seth Levitin, Laurent Bonnac, Krystoff W. Panciewicz, Hiramagular N. Jayaram

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Purpose Benzamide riboside (BR) induces tumor apoptosis in multiple cell lines and animals. This pilot study compares apoptosis and tumor response in rat hepatomas treated with hepatic arterial BR (IA) or intravenous (IV) BR. Methods A total of 10 6 N1-S1 cells were placed in the left hepatic lobes of 15 Sprague-Dawley rats. After 2 weeks, BR (20 mg/kg) was infused IA (n = 5) or IV (n = 5). One animal in each group was excluded for technical factors, which prevented a full dose administration (1 IA and 1 IV). Five rats received saline (3 IA and 2 IV). Animals were killed after 3 weeks. Tumor volumes after IA and IV treatments were analyzed by Wilcoxon rank sum test. The percentage of tumor and normal liver apoptosis was counted by using 10 fields of TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling)-stained slides at 40x magnification. The percentage of apoptosis was compared between IV and IA administrations and with saline sham-treated rats by the Wilcoxon rank sum test. Results Tumors were smaller after IA treatment, but this did not reach statistical significance (0.14 IA vs. 0.57 IV; P = 0.138). There was much variability in percentage of apoptosis and no significant difference between IA and IV BR (44.49 vs. 1.52%; P = 0.18); IA BR and saline (44.49 vs. 33.83%; P = 0.66); or IV BR and saline (1.52 vs. 193%; P = 0.18). Conclusions Although differences in tumor volumes did not reach statistical significance, there was a trend toward smaller tumors after IA BR than IV BR in this small pilot study. Comparisons of these treatment methods will require a larger sample size and repeat experimentation.

Original languageEnglish (US)
Pages (from-to)645-652
Number of pages8
JournalCardioVascular and Interventional Radiology
Volume35
Issue number3
DOIs
StatePublished - Jun 1 2012

Keywords

  • Cancer
  • Chemoembolization/ chemoembolization
  • Experimental IR
  • Hepatocellular carcinoma (HCC)
  • Interventional oncology
  • Liver/hepatic

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside'. Together they form a unique fingerprint.

  • Cite this

    McLennan, G., Bennett, S. L., Ju, S., Babsky, A., Bansal, N., Shorten, M. L., Levitin, S., Bonnac, L., Panciewicz, K. W., & Jayaram, H. N. (2012). Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside. CardioVascular and Interventional Radiology, 35(3), 645-652. https://doi.org/10.1007/s00270-011-0140-z